Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis
Open Access
- 19 August 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
Abstract
Proton pump inhibitors (PPI) are an invaluable therapy option for acid related diseases; however, PPI therapy is also linked to a series of side effects in cirrhosis, such as microbiome alterations, spontaneous bacterial peritonitis and hepatic encephalopathy. Decision tools to balance benefits and risks of PPI therapy are largely missing. In this study, we tested gut-derived biomarkers to identify PPI-associated dysbiosis, its association with gut barrier function and liver-related mortality. In this observational study, faecal microbiome composition data obtained from 16S rDNA sequencing of 90 cirrhotic patients with and without long-term PPI use and additional potential biomarkers identified from the literature were evaluated for their predictive value regarding PPI-associated dysbiosis and liver-related three-year mortality. In addition, faecal calprotectin, faecal zonulin and serum lipopolysaccharides were assessed as markers for intestinal inflammation, gut permeability and bacterial translocation. Streptococcus salivarius, Veillonella parvula and the genus Streptococcus were significantly increased in patients with long-term PPI therapy and performed well as biomarkers for PPI-associated dysbiosis (accuracy: 74%, 72% and 74%, respectively). The abundance of Streptococcus salivarius was linked to intestinal inflammation and gut barrier dysfunction, whereas the abundance of Veillonella parvula showed associations with liver disease severity; both were independent predictors for liver-related three-year mortality. Gut-derived biomarkers of PPI-associated dysbiosis are linked to worse outcome and a potential option to evaluate the risks of adverse events during long-term PPI therapy.Keywords
Funding Information
- Austrian Science Fund (P24362)
This publication has 43 references indexed in Scilit:
- Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing DysbiosisGastroenterology, 2011
- UCHIME improves sensitivity and speed of chimera detectionBioinformatics, 2011
- Search and clustering orders of magnitude faster than BLASTBioinformatics, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Receptor Recognition of and Immune Intracellular Pathways for Veillonella parvula LipopolysaccharideClinical and Vaccine Immunology, 2009
- The Commensal Streptococcus salivarius K12 Downregulates the Innate Immune Responses of Human Epithelial Cells and Promotes Host-Microbe HomeostasisInfection and Immunity, 2008
- Candida albicans and Streptococcus salivarius modulate IL-6, IL-8, and TNF-alpha expression and secretion by engineered human oral mucosa cellsCellular Microbiology, 2004
- Propensity Score-Matching Methods for Nonexperimental Causal StudiesReview of Economics and Statistics, 2002
- Interleukin‐8, a chemotactic and inflammatory cytokineFEBS Letters, 1992
- Ecology of viridans streptococci in the oral cavity and pharynxOral Microbiology and Immunology, 1991